Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AZN
6. ROIV
7. AAPL
8. HOOD
9. QCOM
10. ACN

Go back to Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
(NYSE: LCTX) Delayed: 1.09 +0.01 (0.93%)
Previous Close $1.08    52 Week High $ 
Open $1.10    52 Week Low $ 
Day High $1.16    P/E N/A 
Day Low $1.09    EPS $ 
Volume 1,311,208       

(NYSE: LCTX) Delayed: 1.09 +0.01 (0.93%)
Previous Close $1.08    52 Week High $ 
Open $1.10    52 Week Low $ 
Day High $1.16    P/E N/A 
Day Low $1.09    EPS $ 
Volume 1,311,208